An authorized generic of Epivir-HBV was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (lamivudine) is available.
Source: FDA, updated October 30, 2026
Generic name: lamivudine
Used for: Chronic hepatitis B, when other hepatitis B medicines can’t be used
Lowest without a membership
$300.39 for 30 tablets delivered ($295.14 plus $5.25 shipping)
Generic lamivudine 100 mg from Cost Plus Drugs, by mail
With a membership $218.99 for 30 tablets at Costco ($65 a year).
See Costco’s price listA regular generic has the same active ingredient as Epivir-HBV, and the FDA requires it to work the same way.
Details for each option
Epivir-HBV itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
An authorized generic of Epivir-HBV was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (lamivudine) is available.
Source: FDA, updated October 30, 2026
Pharmacies’ own cash prices for generic lamivudine, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
One company sells a generic of Epivir-HBV that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has lactose
100 mg Orange-brown, oval, 12 mm, marked “APO / LMV100”
| Package | NDC |
|---|---|
| Bottle of 60 | 60505-3250-6 |
Inactive ingredients: anhydrous lactose, crospovidone (120 .mu.m), silicon dioxide, magnesium stearate, hypromellose 2910 (5 mpa.s), hydroxypropyl cellulose (1600000 wamw), polyethylene glycol 8000, titanium dioxide, ferric oxide red, ferric oxide yellow
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
EPIVIR-HBV is indicated for the treatment of chronic hepatitis B virus (HBV) infection associated with evidence of hepatitis B viral replication and active liver inflammation. The following points should be considered when initiating therapy with EPIVIR-HBV:
Source: the FDA label for Epivir-HBV (Glaxosmithkline), December 22, 2021. Full label from the FDA (PDF)
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/epivir-hbv/